RTX Corp: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 7, 2023 and accepted by EDGAR at Feb 6, 2023, 17:32 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 12 months2022-01-01 to 2022-12-31 | $2.71bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | $5.66bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $5.41bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $1.28bn | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $700.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $5.20bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $3.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $3.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 1,485,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $2.29bn | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2022-01-01 to 2022-12-31 | $3.13bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $2.80bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $6.22bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $42.44bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $158.86bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $39.11bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $84.65bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $31.29bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2022-12-31 | $625.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2022-12-31 | $72.63bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000101829-23-000009. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.